US Stock MarketDetailed Quotes

LIPO Lipella Pharmaceuticals

Watchlist
  • 2.420
  • +0.010+0.41%
Close Nov 21 16:00 ET
  • 2.410
  • -0.010-0.41%
Post 17:15 ET
2.93MMarket Cap-564P/E (TTM)

About Lipella Pharmaceuticals Company

Lipella Pharmaceuticals, Inc. develops and commercializes lipid-based therapies for common bladder syndromes. It offers LP-08 which consists of Sphingomyelin Phospholipid bilayers separated by aqueous compartments, LP-09, a liposomal formulation of Botulinum toxin, and LP-10, a proprietary liposomal formulation of Tacrolimus, a potent immunosuppressant and anti-inflammatory agent. The company was founded by Jonathan Kaufman and Michael Chancellor on February 15, 2005 and is headquartered in Pittsburgh, PA.

Company Profile

SymbolLIPO
Company NameLipella Pharmaceuticals
Listing DateDec 20, 2022
Founded2005
CEODr. Jonathan Kaufman, M.B.A.,PhD
MarketNASDAQ
Employees7
Fiscal Year Ends12-31
Address7800 Susquehanna Street,Suite 505
CityPittsburgh
ProvincePennsylvania
CountryUnited States of America
Zip Code15208
Phone1-412-901-0315
Websitehttp://www.lipella.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Jonathan Kaufman, M.B.A.,PhD
  • Chairman of the Board, President, Chief Executive Officer, Secretary and Treasurer
  • 323.38K
  • Douglas Johnston, C.P.A.
  • Chief Financial Officer
  • 260.00K
  • Dr. Michael Chancellor, M.D.
  • Chief Medical Officer and Director
  • 315.08K
  • Daniel R. Cohen, M.B.A.
  • Independent Director
  • 63.63K
  • Dr. Naoki Yoshimura, M.D.,PhD
  • Independent Director
  • 62.50K
  • Ryan Pruchnic, M.B.A.
  • Independent Director
  • 62.50K
  • Dr. Lori Birder, PhD
  • Independent Director
  • 12.50K
  • Dr. Byong Kim, PhD
  • Independent Director
  • 63.30K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data